|
|||||||||||||||||||||||||||||||||||||
|
|
|
A.Vogel: Ginkgo Forte is put to the test! |
  |
  Ginkgo Forte is put to the test! Only a few research groups worldwide have the equipment and experience to carry out modern microcirculation research. The "Institute for Microcirculation" in Berlin is the leading research centre on microcirculation in Europe. We have conducted studies with Dr. Rainer Klopp, Director of the Institute and recognized expert of microcirculation. Below is the spectacular results of one of these microcirculation studies with Ginkgo Forte, plus the result of a product safety and tolerance study done by physicians. A.Vogel Ginkgo Forte: increases the microcirculation in elderly patients1
Study group: 32 healthy individuals aged between 60-70 years old; 16 were treated with A.Vogel Ginkgo Forte and 16 untreated. Dosage: 2x3 tablets/day Method: Intra vital microscopy, investigation in two target tissues (skin on lower arm and gums) Results:
Increase of capillary network in the deep layer
of the skin of a patient's forearm at the beginning and after 30 days
of treatment with Ginkgo Forte.The video content presented here requires JavaScript to be enabled and the latest version of the Macromedia Flash Player. If you are you using a browser with JavaScript disabled please enable it now. Otherwise, please update your version of the free Flash Player by downloading here. A.Vogel Ginkgo Forte tolerance1
Safety trial done by 11 general practitioners in Switzerland in 2004 to assess the safety and tolerance of A.Vogel Ginkgo Forte for elderly patients. Study group: 59 patients (15 men/44 women; average age 72 years old) with mild to moderate memory impairments of the non-Alzheimer type. Treatment duration: 6 weeks Dosage: 2x1 tablet/day Results:
 1 Poster 2004 International Congress on Natural Products Research, July/August 2004, Phoenix AZ |
||
|
|
|
|
 |
||
|
||
 |
||
|
